WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for genetically defined diseases. The Company is engaged in developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. The nucleic acid therapeutics, which the Company is developing are stereopure. A stereopure oligonucleotide includes molecules with atoms arranged in three-dimensional orientations at each linkage. The Company has three programs in Huntington's disease (HD) and Duchenne Muscular Dystrophy (DMD), and three additional development candidates.
https://www.wavelifesciences.com/Wave Life Sciences is an American pharmaceutical company whose main activity is the study of genetic diseases and the development of innovative drugs. It was founded in 2012. One of its founders is the famous American biochemist, professor at Harvard University, Gregory L. Verdin. The company's headquarters is located in Singapore.
Statistics for 2021
Investments and shares
Wave Life Sciences shares are traded on the NASDAQ under the ticker symbol WVE. The total number of shares in circulation is 86.8 mn. About 69.5% of their number belongs to institutional ones. Among the largest:
How can I buy Wave Life Sciences shares as an individual?
Although most of the company's shares are owned by institutional clients, WVE shares can be held by any private investor or trader. To do this:
© 2024 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission in accordance with license No.281/15 issued on 25/09/2015. The "Just2Trade" trademark is owned by LimeTrading (CY) Ltd.
Registration Number: HE 341520
Address: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Disclaimer:
All promotions, materials and information of this website may have applied conditions. Please contact the Company for further details
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.
E-mail: 24_support@just2trade.online
